RSP Systems announces completing €6.5 million in Series B Funding
RSP Systems, an Odense, Denmark-based non-invasive diagnostics company, announces that it has completed the first closing of a Series B funding round amounting to €6.5 million.
The investors round included family offices and private investors, such as Jürgen Hambrecht, Chairman of the Board of BASF and Andreas Jenne, RSP Systems’ new CEO. All of RSP Systems’ present investors also participated in this round. To date, RSP Systems has raised a total of €19.5 million, including the €2.4M Horizon 2020 grant awarded by the EU in 2016.
The round remains open for a second closing due to strong interest.
The proceeds of this round will be used to fund more extensive clinical trials, allowing RSP Systems to prepare for regulatory approval and market launch with a stand out product that will revolutionize the way diabetes is managed.
RSP Systems was founded in 2006 as spinoff from Odense University by Olav Storm Kjestrup, Morten Henneberg, Thomas Juhl and Stefan Oversen Banke. They set out to make Raman spectroscopy a technology that could be practical and useful outside of the lab.